# Enucleation Ratio as a Novel Predictor of Symptomatic Improvement After HoLEP

> **NCT07591688** · — · NOT_YET_RECRUITING · sponsor: **Ondokuz Mayıs University** · enrollment: 400 (estimated)

## Conditions studied

- Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms

## Interventions

- **PROCEDURE:** Holmium laser enucleation of prostate (HoLEP)

## Key facts

- **NCT ID:** NCT07591688
- **Lead sponsor:** Ondokuz Mayıs University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2027-02-01
- **Final completion:** 2027-03-30
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07591688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07591688, "Enucleation Ratio as a Novel Predictor of Symptomatic Improvement After HoLEP". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT07591688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*